Feedback / Questions
Bavencio (avelumab) - EMD Serono, Pfizer
MCC1 TCR - Fred Hutchinson Cancer Research Center, 2seventy bio, Affini-T Therap
Keytruda (pembrolizumab) - Merck (MSD)
http://clinicaltrials.gov/ct2/show/NCT03747484
May 27, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next